Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study.
We estimated the survival and hospitalization among frequent hemodialysis users in comparison to those patients undergoing thrice-weekly conventional hemodialysis. All patients had similar characteristics and medical histories. In this cohort study of frequent hemodialysis users and propensity score-matched controls, the collaborating clinicians identified 94 patients who used nocturnal hermodialysis (NHD) and 43 patients who used short-duration daily hemodialysis (SDHD) for a minimum of 60 days. Ten propensity score-matched control patients for each NHD and SDHD patient were identified from the United States Renal Data System database. Primary outcomes were risk for all-cause mortality and risk for the composite outcome of mortality or major morbid event (acute myocardial infarction or stroke) estimated using Cox proportional hazards models. Risks for all-cause, cardiovascular-related, infection-related, and vascular access-related hospital admissions were also studied. Nocturnal hemodialysis was associated with significant reductions in mortality risk and risk for mortality or major morbid event when compared to conventional hemodialysis. There was a reduced but non-significant risk of death for patients using SDHD compared to controls. All-cause and specific hospitalizations did not differ significantly between NHD and SDHD patients and their matched control cohorts. Our study suggests that NHD may improve patient survival.
Johansen
Kirsten L
KL
USRDS Rehabilitation/QoL Special Studies Center, Emory University, Atlanta, Georgia 30322, USA.
Zhang
Rebecca
R
Huang
Yijian
Y
Chen
Shu-Cheng
SC
Blagg
Christopher R
CR
Goldfarb-Rumyantzev
Alexander S
AS
Hoy
Chistopher D
CD
Lockridge
Robert S
RS
Miller
Brent W
BW
Eggers
Paul W
PW
Kutner
Nancy G
NG
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D019992:Databases as Topic; D005260:Female; D006437:Hemodialysis, Home / Q000009:adverse effects / Q000379:methods / Q000401:mortality*; D006760:Hospitalization / Q000706:statistics & numerical data*; D006801:Humans; D053208:Kaplan-Meier Estimate; D007674:Kidney Diseases / Q000401:mortality* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D016016:Proportional Hazards Models; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D055815:Young Adult
N Engl J Med. 2001 Jan 11;344(2):102-7
11150360
Nephrol Dial Transplant. 1999 Dec;14(12):2835-40
10570083
J Am Soc Nephrol. 2004 Feb;15(2):477-86
14747396
Hemodial Int. 2008 Jul;12(3):281-9
18638080
Kidney Int. 2001 Oct;60(4):1443-51
11576358
Am J Kidney Dis. 2003 Nov;42(5):1020-35
14582046
Kidney Int. 2002 Aug;62(2):620-6
12110026
J Am Soc Nephrol. 2008 Sep;19(9):1792-7
18614773
Kidney Int. 2002 Jun;61(6):2235-9
12028465
J Am Soc Nephrol. 2005 May;16(5):1449-55
15788468
Nephrol Dial Transplant. 2008 Oct;23(10):3283-9
18458034
Am J Kidney Dis. 2003 Jul;42(1 Suppl):49-55
12830444
JAMA. 2007 Sep 19;298(11):1291-9
17878421
JAMA. 2007 Sep 19;298(11):1331-3
17878427
J Am Soc Nephrol. 2005 Sep;16(9):2778-88
16033855
J Am Soc Nephrol. 2001 Dec;12(12):2850-2853
11729257
Adv Ren Replace Ther. 2001 Oct;8(4):273-9
11593493
Clin Nephrol. 2008 Jan;69(1):33-9
18218314
Clin J Am Soc Nephrol. 2006 Jan;1(1):33-42
17699188
Kidney Int. 2005 Apr;67(4):1500-8
15780103
Nephrol Dial Transplant. 2006 Jan;21(1):166-75
16169869
Am J Kidney Dis. 2001 Apr;37(4):777-89
11273878
Nephrol Dial Transplant. 2008 Oct;23(10):3219-26
18511606
Hemodial Int. 2007 Apr;11(2):225-30
17403175
Kidney Int. 1992 May;41(5):1286-91
1614043
Kidney Int. 2007 Feb;71(4):349-59
17164834
Hemodial Int. 2006 Oct;10(4):371-4
17014514
Am J Kidney Dis. 2005 May;45(5):798-803
15861344
Hemodial Int. 2004 Jan 1;8(1):61-9
19379403